New Agents for Heart Failure: Sacubitril/Valsartan

Поделиться
HTML-код
  • Опубликовано: 12 сен 2024
  • Sacubitril/valsartan is a combination neprilysin inhibitor/angiotensin receptor blocker that significantly reduces the risk of all-cause death, cardiovascular death, and heart failure hospitalization, while improving related symptoms

Комментарии • 26